Clinical Trial Lay Summaries
The new EU Clinical Trials Regulation No. 536/2014 requires all clinical trial sponsors to provide lay summaries of the results of their clinical trials within one year of the trial ending
Clinical trial summaries for lay people
– unpicking the guidance
Luto’s co-founder and Academic Advisor, Theo Raynor examines the EU’s guidance document and suggests ways to create clinical trial summaries that the public can understand.
How we can help
We know that clinical trials are complex and that meeting regulatory requirements is vital. Turning your clinical study report into something a lay person can understand, in a non-promotional way, is a challenge that requires time and resource.
Our team has extensive experience of information design, lay writing and knowledge of clinical trials. We have already worked with a number of top pharmaceutical companies to develop lay summary materials – we can help you too.
- Meet regulatory requirements
- Reduce demand on internal resource
- Submit high quality, truly ‘lay’ summaries
What we offer
You may just be setting up your approach to writing lay summaries or already have drafts in the pipeline. We can help whatever stage you may be at and create a project that is bespoke to you.
Our services include:
- Writing a lay summary from a clinical study report synopsis
- Enhancing an existing lay summary
- Creating a lay summary template
- Graphic design and layout
- Proof reading
- Translation into other languages
- Lay person input and review
- User Testing to inform summary design and content
- Training your team in writing for lay readers